Medeva Pharma Schweiz AG
Records under this name other than patents Medeva Pharma Schweiz AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Medeva Pharma Schweiz AG
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 5,541,170 | Orally administrable pharmaceutical compositions Formerly held Term ended Term ended no later than Jul 30, 2016 · Low confidence | Term ended | Term ended no later than Jul 30, 2016 | Low confidence |
| US 5,541,171 | Orally administrable pharmaceutical composition Formerly held Term ended Term ended no later than Jul 30, 2016 · Low confidence | Term ended | Term ended no later than Jul 30, 2016 | Low confidence |
| US 5,792,795 | Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids Formerly held Term ended Term ended no later than Aug 11, 2018 · Low confidence | Term ended | Term ended no later than Aug 11, 2018 | Low confidence |
| US 5,948,818 | Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids Formerly held Term ended Term ended no later than Sep 7, 2019 · Low confidence | Term ended | Term ended no later than Sep 7, 2019 | Low confidence |